Vanguard Group Inc Neuronetics, Inc. Transaction History
Vanguard Group Inc
- $5.57 Trillion
- Q4 2024
A detailed history of Vanguard Group Inc transactions in Neuronetics, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 1,281,390 shares of STIM stock, worth $5.93 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,281,390
Previous 1,299,915
1.43%
Holding current value
$5.93 Million
Previous $987,000
93.41%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding STIM
# of Institutions
49Shares Held
10.1MCall Options Held
24.1KPut Options Held
200-
Kent Lake Capital LLC Mill Valley, CA1.74MShares$8.05 Million1.44% of portfolio
-
Masters Capital Management LLC Atlanta, GA1.5MShares$6.95 Million0.08% of portfolio
-
Balyasny Asset Management LLC Chicago, IL1.48MShares$6.86 Million0.0% of portfolio
-
Four World Capital Management LLC New York, NY858KShares$3.97 Million0.69% of portfolio
-
Parian Global Management LP Pound Ridge, NY830KShares$3.84 Million8.59% of portfolio
About Neuronetics, Inc.
- Ticker STIM
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 27,022,800
- Market Cap $125M
- Description
- Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive diso...